To optimize care pathways with an intelligent decision support system aimed at facilitating diagnosis and therapeutic decisions along disease-specific pathways.
As today’s healthcare delivery system continues to accelerate and evolve key stakeholders from hospital executives to clinicians, are faced with a growing number of challenges in the enabling and sustaining of outcomes-based healthcare. Data overload, interoperability, physician burnout, and overall rising cost of care serve as barriers in the disruption of precise diagnosis, prognosis, and treatment-driven patient outcomes.
Keeping patients at the center of it all
Leveraging data integration and artificial intelligence technology, the solution AI-Pathway Companion with its applications aims to support your multidisciplinary physician team to ease diagnosis and treatment decisions. AI-Pathway Companion may enable personalized and standardized patient management and plans to offer process improvement insights through analysis of key performance indicators. The AI-Pathway Companion product suite could help you to make patient-centric diagnosis and treatment decisions along disease-specific care pathways using augmented intelligence, data integration, and insights from cohort analytics.
Our goals for the AI-Pathway Companion product suite:
- AI-Pathway Companion enables automatic patient-specific mapping along the clinical pathway using evidence-based guidelines4-7
- AI-Pathway Companion facilitates objective decision-making by multi-disciplinary experts on correlated patient data and preferences4
- AI-Pathway Companion offers transparent insights into time to diagnosis and treatment4
- AI-Pathway Companion provides process improvement insights through cohort analysis of performance indicators8
* AI-Pathway Companion is currently under development. It is not for sale and its future availability cannot be guaranteed. AI-Pathway Companion Prostate Cancer does not yet fulfil all the essential requirements according to the European Medical Device Directive (93/42/EEC) and its national implementations.
1Institute of Medicine. 2013. Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. Washington, DC: The National Academies Press.
2Overtreatment in the United States, 2017 lyu et al.
3University of Iowa, Carver College of Medicine report, 2014.
4This function is supported by AI-Pathway Companion Prostate Cancer.
5Prerequisite: “All data is available as required per guideline.”; Feature dependent on quality of input data.
6AI-Pathway Companion Prostate Cancer VA10A supports prostate cancer adenocarcinoma cases only.
7AI-Pathway Companion Prostate Cancer VA10A supports NCCN guidelines. EAU guideline support under development.
8This function is supported by AI-Pathway Companion Analytics.
9This function is supported by AI-Pathway Companion Connector.